OS Therapies Reports Positive OST-HER2 Survival Data at Osteosarcoma Conference

OS Therapies Reports Positive OST-HER2 Survival Data at Osteosarcoma Conference

OS Therapies Reports Positive OST-HER2 Survival Data at Osteosarcoma Conference OS Therapies a clinical-stage biopharmaceutical company specializing in immunotherapy and Antibody Drug Conjugates (ADCs), has announced encouraging clinical data from its ongoing Phase 2b clinical trial of OST-HER2, a promising…

Read MoreOS Therapies Reports Positive OST-HER2 Survival Data at Osteosarcoma Conference
DuPont Launches FilmTec™ Hypershell™ for Energy-Efficient Dairy Processing

DuPont Launches FilmTec™ Hypershell™ for Energy-Efficient Dairy Processing

DuPont Unveils FilmTec™ Hypershell™ XP RO Element for Smarter, Greener Dairy Processing DuPont has announced the launch of its latest innovation for the dairy industry—the FilmTec™ Hypershell™ XP RO-8038 element, an advanced reverse osmosis (RO) solution tailored to increase productivity,…

Read MoreDuPont Launches FilmTec™ Hypershell™ for Energy-Efficient Dairy Processing